Gmo Us Financials

GCAVX Fund  USD 20.49  0.20  0.99%   
Financial data analysis helps to validate if markets are presently mispricing Gmo Us. We were able to interpolate and analyze data for fourteen available reported financial drivers for Gmo Small Cap, which can be compared to its competitors. The fund experiences a moderate upward volatility. Check odds of Gmo Us to be traded at $22.54 in 90 days.
  
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.

Gmo Us Fund Summary

Gmo Us competes with Nationwide Core, Gmo Global, Guidemark, Rbc Funds, and Pro-blend(r) Conservative. The adviser seeks to achieve the funds investment objective by investing primarily in equities of U.S. companies that are included in the SP 600 Index or whose market capitalization at the time of investment is less than that of the 1000 largest publicly held companies. As an alternative to investing directly in equities, it may invest in exchange-traded and OTC derivatives and ETFs. Under normal circumstances, the fund invests directly and indirectly at least 80 percent of its assets in equities tied economically to the United States.
Specialization
Small Value, Large
InstrumentUSA Mutual Fund View All
ExchangeNMFQS Exchange
Business AddressGMO Trust
Mutual Fund FamilyGMO
Mutual Fund CategorySmall Value
BenchmarkDow Jones Industrial
Phone617 346 7646
CurrencyUSD - US Dollar

Gmo Us Key Financial Ratios

Gmo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Gmo Us's current stock value. Our valuation model uses many indicators to compare Gmo Us value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gmo Us competition to find correlations between indicators driving Gmo Us's intrinsic value. More Info.
Gmo Small Cap is one of the top funds in annual yield among similar funds. It also is one of the top funds in year to date return among similar funds creating about  138.23  of Year To Date Return per Annual Yield. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gmo Us' earnings, one of the primary drivers of an investment's value.

Gmo Small Cap Systematic Risk

Gmo Us' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Gmo Us volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Gmo Small Cap correlated with the market. If Beta is less than 0 Gmo Us generally moves in the opposite direction as compared to the market. If Gmo Us Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Gmo Small Cap is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Gmo Us is generally in the same direction as the market. If Beta > 1 Gmo Us moves generally in the same direction as, but more than the movement of the benchmark.
Gmo Small Cap is one of the top funds in net asset among similar funds. Total Asset Under Management (AUM) of Small Value category is currently estimated at about 58.56 Billion. Gmo Us maintains roughly 336.01 Million in net asset contributing less than 1% to funds listed under Small Value category.

Gmo Us March 2, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Gmo Us help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Gmo Small Cap. We use our internally-developed statistical techniques to arrive at the intrinsic value of Gmo Small Cap based on widely used predictive technical indicators. In general, we focus on analyzing Gmo Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Gmo Us's daily price indicators and compare them against related drivers.

Other Information on Investing in Gmo Mutual Fund

Gmo Us financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Us security.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine